CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
41,702,726
Share change
+290,984
Total reported value
$100,832,757
Put/Call ratio
11%
Price per share
$2.42
Number of holders
78
Value change
+$213,610
Number of buys
35
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q3 2014

As of 30 Sep 2014, CTI BIOPHARMA CORP - COM (CTIC) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,702,726 shares. The largest 10 holders included EAGLE ASSET MANAGEMENT INC, State Street Corp, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, FMR LLC, BlackRock Fund Advisors, NORTHERN TRUST CORP, JANE STREET GROUP, LLC, RENAISSANCE TECHNOLOGIES LLC, and TEACHERS ADVISORS INC. This page lists 78 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.